Martin H. Adelman

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory

Jerome J. Schentag, Charles H. Ballow, Albert L. Fritz et al. · Diagnostic Microbiology and Infectious Disease · 1993 · 124 citations

Anti-infective Agents, Health Sciences, Antibiotics +13

Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure

Aileen B Luzier, Alan Forrest, Martin H. Adelman et al. · The American Journal of Cardiology · 1998 · 75 citations

Heart Failure, Cardiogenic Shock, Cardiovascular Disease +12

Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations

Joseph A. Paladino, David M. Jacobs, Ryan K. Shields et al. · International Journal of Antimicrobial Agents · 2014 · 39 citations

Antimicrobial Susceptibility, Antibiotics, Glycopeptide Failure +7

Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care–based collaboration model

Scott V. Monte, Erin M. Slazak, Nicole Paolini Albanese et al. · Journal of the American Pharmacists Association · 2009 · 37 citations

Health Systems, Family Medicine, Primary Care +13

Effects of enteral and intravenous antimicrobial treatment on survival following intestinal ischemia in rats

Andrzej J. Plonka, Jerome J. Schentag, Sol Messinger et al. · Journal of Surgical Research · 1989 · 34 citations

Antibiotics, Medicine, Gastroenterology +9